| |
| |
|
| Insider
Information: |
Orbimed Capital Gp Iv Llc |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
3,027,542 |
|
|
Indirect Shares
|
9,887,970 |
|
|
| Direct
Value |
$14,289,998 |
|
|
|
Indirect Value
|
$396,606,174 |
|
|
| Total
Shares |
12,915,512 |
|
|
| Total
Value |
$410,896,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
12
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
12
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-12.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -390.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Audentes Therapeutics, Inc. |
BOLD |
10% Owner |
|
0 |
2018-03-12 |
3,539,997 |
Premium* |
|
|
Principia Biopharma Inc |
PRNB |
10% Owner |
2018-09-18 |
0 |
2019-05-21 |
1,605,713 |
Premium* |
|
|
Tela Bio, Inc. |
TELA |
10% Owner |
2019-11-13 |
3,027,542 |
2023-04-21 |
2,835,542 |
Premium* |
|
|
Alector, Inc. |
ALEC |
10% Owner |
2020-03-23 |
0 |
2020-04-16 |
1,906,718 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2023-04-21 |
4 |
S |
$9.41 |
$260,657 |
I/I |
(27,700) |
2,835,542 |
0 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2023-04-20 |
4 |
S |
$9.43 |
$266,869 |
I/I |
(28,300) |
2,863,242 |
0 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2023-04-19 |
4 |
S |
$9.30 |
$1,264,800 |
I/I |
(136,000) |
2,891,542 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-04-16 |
4 |
S |
$23.53 |
$1,463,166 |
I/I |
(62,183) |
1,906,718 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-04-14 |
4 |
S |
$23.52 |
$546,393 |
I/I |
(23,231) |
1,921,804 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-04-09 |
4 |
S |
$23.79 |
$6,853,923 |
I/I |
(288,101) |
1,927,440 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-04-08 |
4 |
S |
$23.65 |
$1,953,821 |
I/I |
(82,614) |
1,997,333 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-04-07 |
4 |
S |
$23.10 |
$211,827 |
I/I |
(9,170) |
2,017,374 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-03-31 |
4 |
S |
$24.50 |
$6,125,000 |
I/I |
(250,000) |
2,019,598 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-03-25 |
4 |
S |
$24.66 |
$1,391,095 |
I/I |
(56,411) |
2,080,243 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-03-24 |
4 |
S |
$24.45 |
$1,653,896 |
I/I |
(67,644) |
2,093,927 |
0 |
% |
|
| ALEC |
Alector, Inc. |
10% Owner |
– – • |
2020-03-23 |
4 |
S |
$26.05 |
$380,278 |
I/I |
(14,598) |
2,110,336 |
0 |
% |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2019-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,458,915 |
3,027,542 |
0 |
- |
|
| TELA |
Tela Bio, Inc. |
10% Owner |
– – • |
2019-11-08 |
4 |
B |
$13.00 |
$4,999,995 |
D/D |
384,615 |
1,568,627 |
2.45 |
- |
|
| PRNB |
Principia Biopharma Inc |
10% Owner |
– – • |
2019-05-21 |
4 |
S |
$30.25 |
$30,250,000 |
I/I |
(1,000,000) |
1,605,713 |
0 |
- |
|
| PRNB |
Principia Biopharma Inc |
10% Owner |
– – • |
2018-09-18 |
4 |
B |
$17.00 |
$4,250,000 |
I/I |
250,000 |
2,605,713 |
1.5 |
- |
|
| PRNB |
Principia Biopharma Inc |
10% Owner |
– – • |
2018-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,355,713 |
2,355,713 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
10% Owner |
– – • |
2018-03-12 |
4 |
S |
$34.92 |
$629,859 |
I/I |
(18,003) |
3,539,997 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
10% Owner |
– – • |
2018-03-09 |
4 |
S |
$34.67 |
$2,850,010 |
I/I |
(80,000) |
3,558,000 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
10% Owner |
– – • |
2018-03-08 |
4 |
S |
$34.06 |
$1,990,058 |
I/I |
(58,428) |
3,638,000 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
10% Owner |
– – • |
2018-03-06 |
4 |
S |
$33.03 |
$375,617 |
I/I |
(11,372) |
3,696,428 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
10% Owner |
– – • |
2018-03-05 |
4 |
S |
$36.06 |
$7,212 |
I/I |
(200) |
3,707,800 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
10% Owner |
– – • |
2018-03-02 |
4 |
S |
$35.06 |
$14,827,787 |
I/I |
(421,638) |
3,708,000 |
0 |
- |
|
| BOLD |
Audentes Therapeutics, In... |
Director |
– • • |
2016-07-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
224,238 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
